SCHEMBL13149368

SCHEMBL13149368

Cc1cc(C(=O)N2CCN(Cc3ccccc3)CC2)n(C)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ TSHR P16473 2/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ ALDH1A1 P00352 5/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ HPGD P15428 2/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ NPC1 O15118 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ PARP1 P09874 1/20 0.52
▸ CYP46A1 Q9Y6A2 1/20 0.51
▸ PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13149735 0.87 SIGMAR1 (0.57) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL13149845 0.83 ALDH1A1 (0.52) SMN1; SMN2TSHRMEN1KMT2AALDH1A1
SCHEMBL13149852 0.82 MEN1 (0.50) LMNASMN1; SMN2MAPK1TSHRMEN1
SCHEMBL13242427 0.77 NR2E1 (0.53) LMNAMEN1KMT2AALDH1A1CYP2D6
SCHEMBL9203028 0.76 MEN1 (0.52) LMNASMN1; SMN2MAPK1MEN1KMT2A
SCHEMBL13149714 0.75 EPHX2 (0.51) LMNAMAPK1TSHRMEN1KMT2A
SCHEMBL5909252 0.73 PRKAA2 (0.75) LMNASMN1; SMN2MAPK1TSHRMEN1
SCHEMBL9645824 0.73 KDM4E (0.94) LMNASMN1; SMN2MAPK1TSHRMEN1
SCHEMBL1019998 0.73 KDM4E (0.94) LMNASMN1; SMN2MAPK1TSHRMEN1
SCHEMBL7130439 0.73 LMNA (0.72) LMNASMN1; SMN2MAPK1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130072497-A1 N- SUBSTITUTED PIPERAZINES DOW AGROSCIENCES LLC (US) 2013-03-21 — — US disclosed
US-20130072497-A1 N- SUBSTITUTED PIPERAZINES DOW AGROSCIENCES LLC (US) 2013-03-21 — — US disclosed
US-8338430-B2 N-substituted piperazines DOW AGROSCIENCES, LLC. (US) 2012-12-25 — — US disclosed
US-8338430-B2 N-substituted piperazines DOW AGROSCIENCES, LLC. (US) 2012-12-25 — — US disclosed
US-20100234391-A1 N-SUBSTITUTED PIPERAZINES DOW AGROSCIENCES LLC (US) 2010-09-16 — — US disclosed
US-20100234391-A1 N-SUBSTITUTED PIPERAZINES DOW AGROSCIENCES LLC (US) 2010-09-16 — — US disclosed
US-7754724-B2 N-substituted piperazines DOW AGROSCIENCES LLC (US) 2010-07-13 — — US disclosed
US-7754724-B2 N-substituted piperazines DOW AGROSCIENCES LLC (US) 2010-07-13 — — US disclosed
US-20070004750-A1 N-substituted piperazines CORTEVA AGRISCIENCE LLC 2007-01-04 — — US disclosed
US-20070004750-A1 N-substituted piperazines CORTEVA AGRISCIENCE LLC 2007-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004750-A1 N-substituted piperazines PRXL2A, CNPY2, CYP4X1 LMNA 3135/4885SMN1; SMN2 2322/4885MAPK1 2042/4885
US-20100234391-A1 N-SUBSTITUTED PIPERAZINES PRXL2A, CNPY2, CYP4X1 LMNA 3135/4885SMN1; SMN2 2322/4885MAPK1 2042/4885
US-20130072497-A1 N- SUBSTITUTED PIPERAZINES PRXL2A, CNPY2, CYP4X1 LMNA 3135/4885SMN1; SMN2 2322/4885MAPK1 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback